American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1385)
  9. Gastrointestinal Oncology Service (1358)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (82)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (51)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (310)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (308)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8715)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (13)

More Publications

Results (9200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer
    Meeting Abstract

    Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Vornik, L.; Cornelison, T. L.; Hershman, D. L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A randomized, double-blind, controlled trial of methylphenidate for fatigue in patients with advanced cancer
    Meeting Abstract

    Bruera, E.; Valero, V.; Breitbart, W.; Guo, Y.; Palmer, J. L.; Cohen, M. Z.; Scott, C.; Lake, M. B.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Impact of subspecially, clinical volume, and years of practice in selection of treatment sequencing in the management of localized extremity soft tissue sarcoma
    Meeting Abstract

    Canter, R. J.; Wasif, N.; Tamurian, R. M.; Christensen, S.; Do, L.; Martinez, S. R.; Chen, S.; Brennan, M. F.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of AGS-1C4D4, an anti-PSCA human antibody in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Carducci, M. A.; Eisenberger, M. A.; Denmeade, S. R.; Slovin, S. F.; Jakobovits, A.; Vincent, M.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I pharmacokinetic (PK) and biodistribution study of radium-223 chloride in patients with castration resistant prostate cancer (CRPC) metastatic to bone
    Meeting Abstract

    Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Rathkopf, D. E.; Aksnes, A.; Viner, C. L.; Hong, C. T.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II randomized study of ramucirumab (IMC-1121B) with or without dacarbazine (DTIC) in patients (pts) with metastatic melanoma (MM)
    Meeting Abstract

    Carvajal, R. D.; Wong, M. K.; Thompson, J. A.; Gordon, M. S.; Lewis, K. D.; Pavlick, A. C.; Wolchok, J. D.; Fox, F. E.; Schwartz, J. D.; Badikian, A. Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of over 6,000 patients in randomized phase II and III studies
    Meeting Abstract

    Cassidy, J.; Saltz, L.; Van Cutsem, E.; Hedrick, E. E.; Lasserre, S.; Sirzen, F.; Rohr, U. P.; Hurwitz, H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Hypogammaglobulinemia in pts receiving rituximab immunotherapy and the impact of rituximab maintenance
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation
    Meeting Abstract

    Cercek, A.; Weiser, M. R.; Goodman, K. A.; Reidy, D. L.; Wong, W. D.; Guillem, J. G.; Temple, L. K.; Schrag, D.; Paty, P.; Saltz, L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Anthracycline-related cardiomyopathy in childhood cancer survivors and association with polymorphisms in the carbonyl reductase genes: A Children's Oncology Group study
    Meeting Abstract

    Blanco, J. G.; Sun, C.; Landier, W.; Chen, L.; Oeffinger, K. C.; Hudson, M. M.; Neglia, J. P.; Ritchey, A. K.; Reiling, M. V.; Bhatia, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save